Get startedLog in
    Picture of Fermenta Biotech logo

    506414 — Fermenta Biotech Income Statement

    0.000.00%
    in flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapHigh Flyer
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual income statement for Fermenta Biotech, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

    2020
    March 31st
    2021
    March 31st
    2022
    March 31st
    2023
    March 31st
    2024
    March 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSPRESS
    Standards:
    IAS
    IAS
    IAS
    IAS    		—
    Status:FinalFinalFinalFinalFinal
    Revenue
    Total Revenue2,9293,7733,9853,4993,357
    Cost of Revenue
    Gross Profit1,9162,2002,1331,6832,055
    Selling / General / Administrative Expenses
    Depreciation and Amortization
    Unusual Expense / Income
    Other Operating Expenses
    Total Operating Expenses2,4263,1473,6263,8803,403
    Operating Profit504626359-381-46.4
    Gain / Loss on Sale of Assets
    Total Net Non Operating Interest Income / Expense
    Other Net Non Operating Costs
    Net Income Before Taxes434516269-519-98.7
    Provision for Income Taxes
    Net Income After Taxes383425151-536-240
    Minority Interest
    Equity in Affiliates
    Net Income Before Extraordinary Items
    Extraordinary Items
    Net Income595455154-515-231
    Income Available to Common Shareholders Excluding Extraordinary Items
    Income Available to Common Shareholders Including Extraordinary Items
    Diluted Net Income595455154-515-231
    Diluted Weighted Average Shares
    Basic EPS Including Extraordinary Items
    Diluted EPS Including Extraordinary Items
    Diluted EPS Excluding Extraordinary Items
    Normalised Income Before Taxes
    Normalised Income After Taxes
    Normalised Income Available to Common Shareholders
    Diluted Normalised EPS13.415.75.33-11.4-6.32
    Dividends per Share